QIAGEN $12.1 billion takeover offer by EQT Private Equity
We are advising QIAGEN on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
McKesson $1.4 billion investment in Option Care Health
We are advising McKesson on the transaction
McKesson $2.25 billion acquisition of Precision Medicine Group
We are advising McKesson on the transaction
PetIQ acquisition of MYOS
We advised Bansk Group and its portfolio company PetIQ on the transaction
Integer Holdings $5.7 billion sale to KKR
We are advising Integer on the transaction
Clarivate sale of Life Sciences & Healthcare segment to Altaris
We are advising Clarivate on the transaction
TARGAN sale to Merck Animal Health
We are advising TARGAN on the transaction
GSK $10.6 billion acquisition of Nuvalent
We are advising GSK on the transaction
Roche acquisition of SAGA Diagnostics
We advised Roche on the transaction
Ingenovis Health comprehensive restructuring transactions
We advised Ingenovis Health in connection with the restructuring